1
Clinical Trials associated with HPV-16 targeted mRNA vaccine(Novi Technology) / RecruitingNot Applicable Safety and Efficacy Study of NWRD09 in HPV-16 Positive and HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer Patients.
This is a single-arm, open label, two cohorts, multi-center clinical study to evaluate the safety and efficacy of HPV-16 targeted mRNA vaccine (NWRD09) in HPV-16 positive and HPV-16 related cervical, vaginal, and vulvar intraepithelial neoplasia (LSIL and HSIL) patients (cohort A) and HPV-16 related cervical cancer patients (cohort B).
100 Clinical Results associated with HPV-16 targeted mRNA vaccine(Novi Technology)
100 Translational Medicine associated with HPV-16 targeted mRNA vaccine(Novi Technology)
100 Patents (Medical) associated with HPV-16 targeted mRNA vaccine(Novi Technology)
100 Deals associated with HPV-16 targeted mRNA vaccine(Novi Technology)